Загрузка...
Prognostic value of Bcl‐2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
We have analyzed the predictive/prognostic value of Bcl‐2 protein in breast cancer patients treated with neoadjuvant chemotherapy. One hundred and ten patients were submitted to two different chemotherapeutic regimens: a) 5‐fluorouracil, adriamycin or epirubicin, and cyclophosphamide (FAC/FEC) durin...
Сохранить в:
| Опубликовано в: : | Mol Oncol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527786/ https://ncbi.nlm.nih.gov/pubmed/19383332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.01.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|